Re: HCV Pardigms 2010-2017
Was that posted before on here? The only minor difference between that graph and the one on page 3 of the most recent IDIX annual report is that the timeframe in the fourth box of the annual report is ~2014-2017, as opposed to ~2015-2017. Also, the annual report lists a 2nd gen nuke in the fourth box instead of just a nuke. Finally, it should clearly be noted that both graphs fail to include NS4A antagonists as a possible treatment option in the fourth box (LOL yes I'm wearing my ACHN hat right now, but no I don't seriously expect an NS4A antagonist to wind up as part of the HCV paradigm; ACH-1095 represents nothing but an iron in the fire, so to speak, for ACHN at this point).
